» Articles » PMID: 25316553

Clearing the Confusion over Hepatic Encephalopathy After TIPS Creation: Incidence, Prognostic Factors, and Clinical Outcomes

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2014 Oct 16
PMID 25316553
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the incidence, prognostic factors, and clinical outcomes of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) creation.

Materials And Methods: In this single-institution retrospective study, 191 patients (m:f = 114:77, median age 54 years, median Model for End-Stage Liver Disease or MELD score 14) who underwent TIPS creation between 1999 and 2013 were studied. Medical record review was used to identify demographic characteristics, liver disease, procedure, and outcome data. Post-TIPS HE within 30 days was defined by new mental status changes and was graded according to the West Haven classification system. The influence of data parameters on HE occurrence and 90-day mortality was assessed using binary logistic regression.

Results: TIPS was successfully created with hemodynamic success in 99 % of cases. Median final PSG was 7 mmHg. HE incidence within 30 days was 42 % (81/191; 22 % de novo, 12 % stable, and 8 % worsening). Degrees of HE included grade 1 (46 %), grade 2 (29 %), grade 3 (18 %), and grade 4 (7 %). Medical therapy typically addressed HE, and shunt reduction was necessary in only three cases. MELD score (P = 0.020) and age (P = 0.009) were significantly associated with HE development on multivariate analysis. Occurrence of de novo HE post-TIPS did not associate with 90-day mortality (P = 0.400), in contrast to worsening HE (P < 0.001).

Conclusions: The incidence of post-TIPS HE is non-trivial, but symptoms are typically mild and medically managed. HE rates are higher in older patients and those with worse liver function and should be contemplated when counseling on expected TIPS outcomes and post-procedure course.

Citing Articles

Ammonia and beyond - biomarkers of hepatic encephalopathy.

Gallego J, Ballester M, Fiorillo A, Casanova-Ferrer F, Lopez-Gramaje A, Urios A Metab Brain Dis. 2025; 40(1):100.

PMID: 39812958 PMC: 11735499. DOI: 10.1007/s11011-024-01512-7.


The Role of Vitamin D Deficiency in Hepatic Encephalopathy: A Review of Pathophysiology, Clinical Outcomes, and Therapeutic Potential.

Johnson C, Stevens C, Bennett M, Litch A, Rodrigue E, Quintanilla M Nutrients. 2024; 16(23).

PMID: 39683402 PMC: 11643663. DOI: 10.3390/nu16234007.


CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts.

Lucatelli P, Krajina A, Loffroy R, Miraglia R, Pieper C, Franchi-Abella S Cardiovasc Intervent Radiol. 2024; 47(12):1710-1726.

PMID: 39550753 DOI: 10.1007/s00270-024-03866-y.


The Value of Ammonia as a Biomarker in Patients with Cirrhosis.

Ballester M, Durmazer E, Qi T, Jalan R Semin Liver Dis. 2024; 44(3):356-368.

PMID: 39095029 PMC: 11449525. DOI: 10.1055/a-2378-8942.


Hepatic encephalopathy post-TIPS: Current status and prospects in predictive assessment.

Xu X, Yang Y, Tan X, Zhang Z, Wang B, Yang X Comput Struct Biotechnol J. 2024; 24:493-506.

PMID: 39076168 PMC: 11284497. DOI: 10.1016/j.csbj.2024.07.008.


References
1.
Nolte W, Wiltfang J, Schindler C, Munke H, Unterberg K, Zumhasch U . Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations. Hepatology. 1998; 28(5):1215-25. DOI: 10.1002/hep.510280508. View

2.
Gaba R, Omene B, Podczerwinski E, Knuttinen M, Cotler S, Kallwitz E . TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period. J Vasc Interv Radiol. 2011; 23(2):227-35. DOI: 10.1016/j.jvir.2011.10.015. View

3.
Tong C, Xu X, Liu C, Zhang T, Qu K . Assessment of liver volume variation to evaluate liver function. Front Med. 2012; 6(4):421-7. DOI: 10.1007/s11684-012-0223-5. View

4.
Riggio O, Angeloni S, Salvatori F, De Santis A, Cerini F, Farcomeni A . Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008; 103(11):2738-46. DOI: 10.1111/j.1572-0241.2008.02102.x. View

5.
Bajaj J, Wade J, Sanyal A . Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009; 50(6):2014-21. DOI: 10.1002/hep.23216. View